Prudential Financial Inc Sage Therapeutics, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 50,370 shares of SAGE stock, worth $288,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,370

Previous 23,570 113.7%

Holding current value

$288,620

Previous $255,000 42.35%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.02 - $13.08 $188,136 - $350,544	26,800 Added 113.7%	50,370 $363,000
Q2 2024 Aug 13, 2024	BUY	$10.58 - $17.9 $79,297 - $134,160	7,495 Added 46.63%	23,570 $255,000
Q1 2024 May 14, 2024	BUY	$18.62 - $26.95 $299,316 - $433,221	16,075 New	16,075 $301,000
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $9,660 - $13,083	-300 Reduced 1.0%	29,610 $0
Q3 2022 Nov 04, 2022	BUY	$32.28 - $43.27 $216,114 - $289,692	6,695 Added 28.84%	29,910 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $1.36 Million - $1.88 Million	-49,520 Reduced 68.08%	23,215 $750,000
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $1.91 Million - $2.85 Million	-62,300 Reduced 46.14%	72,735 $2.41 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $385,424 - $489,944	10,400 Added 8.34%	135,035 $5.74 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.22 Million - $1.73 Million	-30,200 Reduced 19.5%	124,635 $5.52 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $6.12 Million - $8.84 Million	111,545 Added 257.67%	154,835 $8.8 Million
Q1 2021 May 12, 2021	SELL	$70.65 - $96.76 $286,697 - $392,652	-4,058 Reduced 8.57%	43,290 $3.24 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $1.27 Million - $1.94 Million	21,758 Added 85.03%	47,348 $4.1 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $728,001 - $1.11 Million	17,700 Added 224.33%	25,590 $1.57 Million
Q2 2020 Aug 12, 2020	BUY	$25.95 - $43.15 $204,148 - $339,461	7,867 Added 34204.35%	7,890 $328,000
Q1 2020 Aug 05, 2021	SELL	$26.15 - $77.24 $626,318 - $1.85 Million	-23,951 Reduced 99.9%	23 $1,000
Q1 2020 May 12, 2020	BUY	$26.15 - $77.24 $624,801 - $1.85 Million	23,893 Added 29497.53%	23,974 $688,000
Q4 2019 Aug 05, 2021	SELL	$60.18 - $154.77 $2.08 Million - $5.35 Million	-34,592 Reduced 99.77%	81 $6,000
Q4 2019 Feb 11, 2020	BUY	$60.18 - $154.77 $2.08 Million - $5.35 Million	34,552 Added 28555.37%	34,673 $2.5 Million
Q3 2019 Aug 05, 2021	SELL	$140.29 - $189.96 $332,347 - $450,015	-2,369 Reduced 95.14%	121 $17,000
Q3 2019 Nov 13, 2019	BUY	$140.29 - $189.96 $331,224 - $448,495	2,361 Added 1830.23%	2,490 $349,000
Q2 2019 Aug 05, 2021	SELL	$157.85 - $183.09 $372,683 - $432,275	-2,361 Reduced 94.82%	129 $24,000
Q2 2019 Aug 08, 2019	BUY	$157.85 - $183.09 $379,471 - $440,148	2,404 Added 2795.35%	2,490 $0
Q1 2019 Aug 05, 2021	SELL	$89.33 - $163.65 $205,816 - $377,049	-2,304 Reduced 96.4%	86 $14,000
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $209,121 - $383,104	2,341 Added 4777.55%	2,390 $0
Q4 2018 Aug 05, 2021	SELL	$81.94 - $139.71 $183,627 - $313,090	-2,241 Reduced 97.86%	49 $5,000
Q3 2018 Nov 07, 2018	BUY	$138.11 - $169.04 $13,811 - $16,904	100 Added 4.57%	2,290 $0
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $284,930 - $356,792	-2,030 Reduced 48.1%	2,190 $0
Q1 2018 May 04, 2018	BUY	$152.15 - $192.33 $55,686 - $70,392	366 Added 9.5%	4,220 $0
Q4 2017 Feb 13, 2018	BUY	$60.72 - $167.34 $2,185 - $6,024	36 Added 0.94%	3,854 $635,000
Q3 2017 Nov 02, 2017	BUY	$61.4 - $88.52 $234,425 - $337,969	3,818	3,818 $238,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Sage Therapeutics, Inc. Transaction History